December 2019
Volume 19, Issue 15
Open Access
OSA Fall Vision Meeting Abstract  |   December 2019
Psychiatric Treatment by Light to the Eyes
Author Affiliations
  • Michael Terman, Ph.D.
    Dept. of Psychiatry, Columbia University and Center for Environmental Therapeutics, New York, New York USA
Journal of Vision December 2019, Vol.19, 14. doi:https://doi.org/10.1167/19.15.14
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Michael Terman; Psychiatric Treatment by Light to the Eyes. Journal of Vision 2019;19(15):14. doi: https://doi.org/10.1167/19.15.14.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Light treatment stands as the first active clinical intervention for major depression, with an underpinning in basic lab research on the circadian timing system and seasonal physiological changes in animals. By contrast, pharmaceutical treatments were discovered as side effects of drugs targeted at other medical disorders. The first randomized, controlled clinical trial showed that winter depression (seasonal affective disorder) could remit by truncating long winter nights with bright artificial light in late evening and early morning. Morning light proved most effective, which implicated a change in circadian timing. Seasonality, however, is not essential for the light effect: The much larger cohort of patients with non-seasonal depression also responds to morning light. Bipolar depression can remit as quickly as after a single night awake, but with high risk of relapse after sleep the next night. By adding daily morning light treatment after the night awake, the remission is sustained. Circadian rhythm sleep disorders, especially with sleep onset insomnia, can be normalized by timed light treatment, avoiding recourse to hypnotic drugs. New applications of light treatment with promising initial data include attention deficit hyperactivity disorder, fibromyalgia and other pain disorders, and symptoms of Parkinson's disease and dementia.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×